Computational and Comparative In Vitro Evaluation of GC–MS Profiled Cannabis sativa Inflorescence Extracts’ Metabolites on Selected Diabetes Therapeutic Targets
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71684 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Rosa M Chinheya und 6 weiteren Autor:innen. Beteiligte Einrichtung: African Medicines Innovations and Technologies Development (AMIDT) Unit, Department of Pharmacology, University of the Free State, Bloemfontein, Sout…. Hauptthemen laut MEDLINE: Cannabis, Plant Extracts, Hypoglycemic Agents, Inflorescence. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Cannabis sativa , a medicinal plant rich in cannabinoids, terpenoids, and flavonoids, has been shown to have various pharmacological activities. This study investigated the antidiabetic potential of C. sativa inflorescence extracts using in vitro and computational models. Dried C. sativa inflorescences were extracted sequentially with hexane, dichloromethane, and methanol, before their metabolites were identified by GC–MS. The extracts were tested for α‐amylase and α‐glucosidase inhibition, glucose uptake activity, and antioxidant effects using DPPH and nitric oxide (NO) inhibition assays. Thirty‐six metabolites were further docked against diabetes‐related proteins. Among the extracts, the hexane extract showed the strongest bioactivity with notable α‐amylase inhibition (IC 50 : 727 µg/mL), DPPH free radical scavenging (IC 50 : 478.62 µg/mL), and nitric oxide inhibition activity (IC 50 : 356.51 µg/mL). Docking analyses revealed strong binding affinities for 8‐hydroxy‐delta‐9‐THC, cannabivarin, and 9‐tetrahydrocannabinol with DPP‐4, PTP1B, and other target proteins. These findings highlight the potential of C. sativa inflorescences as a source of antidiabetic agents, warranting further in vivo and clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- African Medicines Innovations and Technologies Development (AMIDT) Unit, Department of Pharmacology, University of the Free State, Bloemfontein, South Africa.
- Department of Biochemistry, Faculty of Science, University of Yaoundé 1, Yaoundé, Cameroon.
- Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Enugu State University of Science and Technology, Enugu, Nigeria.
ORCID-Profile: Rosa M Chinheya, Viviane L N Ngoungoure, Ibeabuchi Ali, Kolawole Olofinsan, Motlalepula G Matsabisa
Zitieren
APA
Chinheya, R. M., Ngoungoure, V. L. N., Ali, I., Olofinsan, K., Jim, T., Tankeu, F., & Matsabisa, M. G. (2026). Computational and Comparative In Vitro Evaluation of GC–MS Profiled Cannabis sativa Inflorescence Extracts’ Metabolites on Selected Diabetes Therapeutic Targets. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71684
Vancouver
Chinheya RM, Ngoungoure VLN, Ali I, Olofinsan K, Jim T, Tankeu F, et al. Computational and Comparative In Vitro Evaluation of GC–MS Profiled Cannabis sativa Inflorescence Extracts’ Metabolites on Selected Diabetes Therapeutic Targets. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71684
BibTeX
@article{Chinheya2026,
author = {Chinheya, Rosa M and Ngoungoure, Viviane L N and Ali, Ibeabuchi and Olofinsan, Kolawole and Jim, Tsebo and Tankeu, Francine and Matsabisa, Motlalepula G},
title = {Computational and Comparative In Vitro Evaluation of GC–MS Profiled Cannabis sativa Inflorescence Extracts’ Metabolites on Selected Diabetes Therapeutic Targets},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71684}
}
EUVIMED